难治性心绞痛:阻塞性与非阻塞性慢性心肌缺血综合征的机制及分层治疗
本文重新定义了难治性心绞痛,将冠脉微循环障碍、冠脉痉挛和心肌桥等非阻塞性机制纳入其中,并建议系统检查以明确缺血机制并分层治疗,同时提出多学科心绞痛心脏团队模式以改善症状、生活质量和临床结局。
要点
- 难治性心绞痛应涵盖阻塞性与非阻塞性冠脉缺血机制。
- 非阻塞性机制(微循环障碍、痉挛、心肌桥)常被漏诊致治疗不足。
- 建议多学科心绞痛心脏团队进行综合评估与分层治疗。
核心结论
- 建议重新定义难治性心绞痛,纳入所有尽管接受当前最大程度指南导向药物和血运重建治疗仍持续存在心绞痛的患者。
研究设计与样本
- 本文为综述,未报告系统检索范围或样本量。
主要发现
- 传统难治性心绞痛诊断限于阻塞性心外膜冠状动脉病所致缺血且经最佳药物和血运重建仍持续症状的患者。
- 心绞痛也可由冠脉微循环障碍、冠脉痉挛和心肌桥所致缺血引起,而无阻塞性心外膜冠状动脉病或血运重建成功后仍可发生。
- 阻塞性心外膜冠状动脉病患者中,微循环和血管运动功能紊乱等机制可解释血运重建后持续症状。
- 对这些机制认识不足导致治疗不充分和症状持续。
关键数值与推荐
- 建议系统全面检查以识别缺血潜在机制并据此分层治疗。
临床怎么用
- 临床应识别非阻塞性缺血机制,避免漏诊和治疗不足。
- 建议由多学科心绞痛心脏团队综合管理难治性心绞痛患者。
局限性
- 本文为综述,未报告原始研究数据或系统评价方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnosis of refractory angina has conventionally been limited to patients with angina and ischaemia secondary to obstructive atherosclerotic epicardial coronary disease who experience persistent symptoms despite optimal pharmacological and revascularization therapies. It is now well-established that angina may also be caused by ischaemia resulting from coronary microcirculatory disorders, coronary vasospasm, and bridging in the absence of obstructive epicardial coronary disease or after "successful" revascularization. This increasingly prevalent and symptomatic group of patients, with both angina and demonstrable ischaemia, have been excluded from the conventional definition of refractory angina. In patients with obstructive epicardial coronary disease, disturbed microcirculatory and vasomotor function, amongst other ischaemic mechanisms, may account for continuing symptoms despite revascularization. Under-recognition of these mechanisms results in inadequate treatment and symptom persistence. In this review, a redefinition of refractory angina is proposed to include the full spectrum of patients experiencing persistent angina despite current maximal guideline-directed medical and revascularization therapies. Systematic approaches for comprehensive investigation are suggested to identify underlying mechanisms of ischaemia and stratify treatments accordingly. The complex needs of patients with refractory angina are likely best addressed by an inter-disciplinary Angina Heart Team with the aim of improving patient symptoms, quality of life, and clinical outcomes.
引用
- de Silva R, Cheng K, Henry TD, et al. Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes. Eur Heart J. 2025. PMID: 40590516. doi:10.1093/eurheartj/ehaf284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。